Diabetes and obesity, commonly referred to as diabesity, also compound the risk of HF, and hence T2DM with obesity warrants regular screening for HF, and NT-proBNP can be a useful tool for the same [23,24]. This evidence concerns the gene NPPB and diabetes mellitus.